Related Experiment Video
Updated: Mar 20, 2026
04:40
Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
3.4K
Breast cancer-associated venous thromboembolism: A case-control study
Danilo Rebouças1, Maria Costa2, Luiz Thuler3
1Department of Medical Oncology, Instituto Nacional de Câncer, Rua Visconde de Santa Isabel 274, Rio de Janeiro 20560-120, Brazil.
Breast (Edinburgh, Scotland)
|June 3, 2016
Summary
Venous thromboembolism (VTE) is common in breast cancer patients, often occurring early in treatment. Age over 50, poor performance status, and central venous catheters significantly increase VTE risk.
Area of Science:
- Oncology
- Hematology
- Clinical Research
Background:
- Venous thromboembolism (VTE) is a serious complication in breast cancer patients, leading to increased morbidity and mortality.
- Risk factors and prognosis of VTE in this population are not well-understood.
- Early identification and management of VTE are crucial for improving patient outcomes.
Purpose of the Study:
- To identify baseline and treatment characteristics predicting VTE occurrence in breast cancer patients.
- To evaluate the prognosis of VTE in breast cancer patients.
- To inform risk stratification and potential preventative strategies for VTE.
Main Methods:
- A case-control study was conducted involving breast cancer patients diagnosed with VTE between 2007 and 2011.
- 225 VTE cases were compared with 225 control patients without VTE.
- Data collected included patient demographics, cancer characteristics, treatment, and VTE details.
Main Results:
- The majority of VTE events were unilateral lower extremity thromboses, predominantly proximal.
- VTE occurred most frequently within the first three years post-diagnosis, particularly in the initial six months.
- Significant predictors for VTE included age (≥50 years), Eastern Cooperative Oncology Group Performance Status (ECOG PS ≥3), and the presence of a central venous catheter (CVC).
Conclusions:
- VTE in breast cancer patients often manifests early in the disease course.
- Patient age, performance status, and CVC use are key factors associated with VTE incidence.
- Further prospective research is recommended to explore the efficacy of outpatient thromboprophylaxis in high-risk breast cancer patients.
Related Concept Videos
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
422
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
422
01:29Venous Thrombosis III: Interprofessional Care
456
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
456
01:30Venous Thrombosis I: Introduction
642
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
642
01:30Venous Thrombosis IV: Nursing Management
363
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
363
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
630
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
630
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
281
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
281